Synthesis and biological evaluation of pyridine-3-carboxamide derivatives as ligands of cannabinoid receptors

(1)

78

(2)

79

1. Cristiana Moliterni, V. M. Luigi Cattivelli, P. Ranalli and Giuseppe Mandolino. 2005. The sexual differentiation of Cannabis sativa L.: A morphological and molecular study. Euphytica 140(1-2): 95-106. Retrieved on 25 Feb 2007.

2. Bouquet, R.J.1950. Cannabis. United Nations Office on Drugs and Crime. Retrieved on 5 Oct 2006.

3._{Current medicinal chemistry 2005, 12, (1217/1237).}

4. Howlett, A.C.; Barth, F.; Bonner, T. I.; Cabral, G.; Casellas, P.; Devane, W.A.; Felder, C.C.; Herkenham, M.; Mackie, K.; Martin, B.R.; Mechoulam, R.; Pertwee, R.G. Pharmacol. Rev., 2002, 54, 161.

5. Piomelli, D. Nat. Rev. Neurosci., 2003, 4, 873.

6. Demuth DG, Molleman A. Cannabinoid signaling. Life Sci. 2006;78:549-563.

7. Lu, Q.; Striker, A.; Lu, Q.; Maguire, G. Vis. Neurosci., 2000, 17, 91.

8. Casanova, M. L.; Blazquez, C.; Martinez-Palacio, J.; Villanueva, C.; Ferdandez- Acenero, M.J., Huffaman, J. Clin. Invest., 2003, 111, 43.

9. Sanchez, C.; Ceballos, M. L., Gomez del Pulgar, T.; Rueda, D.; Cancer Res., 2001, 61, 5784.

10. Cota D, Woods SC. The role of the endocannabinoid system in the regulation of energy homeostasis. Curr Opin Endocrinol Diabetes_{. 2005;12:338-351.}

11. Pagotto U, Marsicano G, Cota D, Lutz B, Pasquali R. The emerging role of the endocannabinoid system in endocrine regulation and energy balance. Endocr Rev. 2006;27:73-100.

12. Nie, J.; Lewis, D.L. Neuroscience., 2001, 107, 161.

13. Katona I, Freud TF. Endocannabinoid signaling as a synaptic circuit breaker in neurological disease. Nat Med 2008; 14:923-30.

14. Howlett AC. Cannabinoid receptor signaling. Handb Exp Pharmacol 2005; 168:53-79.

15. Mackie K. Signaling via CNS cannabinoid receptors. Mol Cell Endocrinol 2008;286:S60-5

(3)

80

16. Bisogno T, Di Marzo V. Short- and long-term plasticity of the endocannabinoid system in neuropsychiatric and neurological disorders. Pharmacol Res 2007; 56:428-42.

17. Moreira FA, Lutz B. The endocannabinoid system:emotion, learning and addiction. Addict Biol 2008; 13:196-212.

18. V.Di Marzo, Pharmacological Research 60 (2009) 77-84.

19. Feng, W. ; Song, Z.H. FEBS Lett., 2001 , 501, 166_.

20. Feng, W. ; Song, Z.H. Biochem. Pharmacol., 2003, 65, 1077.

21. Manera C., Tuccinardi T., Martinelli A., Indoles and Related Compounds as Cannabinoid Ligands, Mini-Reviews in Medicinal Chemistry,2008, 8, 370-387.

22.Thomas, S.R.; Chen, K.; Keaney, J.F. Jr. Antioxidant Redox Signal, 2003, 5, 181_.

23._{Nelson, E.J.; Connolly, J.; McArthur, P. Biol.Cell, 2003, 95,3.}

24._{Giulivi, C. Free Radic, Biol. Med., 2003, 34, 397.}

25._{Maccarrone, M.; Bari, M.;Lorenzon, T.; Bisogno, T.; Di Marzo, V.; Finazzi-Agro,} A. J. Biol. Chem., 2000, 275, 13484.

26. Grainger, J.; Boachie-Ansah, G. Br. J. Pharmacol., 2001, 134, 1003.

27. Manera C., Tuccinardi T., Martinelli A. Mini-Reviews in Medicinal Chemistry, 2008, 8, 370-387 1389-5575/08 Indoles and Related Compounds as Cannabinoid Ligands.

28. Inaba, T.; Kaya, T.; Iwamura, H.I. W.O. Patent 00/40562, 2000.

29. Manera C., et all. Design, Synthesis, and Biological Evaluation of new 1,8-Naphtyridin-4(1H)-on-3-carboxamide and Quinolin-4(1H)-on-3-carboxamide derivatives as CB2 selective agonists, J. Med. Chem. 2006, 49, 5947-5957.

30. Manera C. et all. New 1,8-Naphtyridine and quinoline derivatives as CB2 selective agonists, Biorganic and Medicinal Chemistry Letters 17 (2007) 6505-6510.

(4)

81

32. T. Tuccinardi, P.L. Ferrarini, C. Manera, G. Ortore, G. Saccomanni, and A. Martinelli. J. Med. Chem. 2006, 49, 984-994.

33. Stern et all.; CB2-Selective Cannabinoid Receptor Ligands; J. Med. Chem. 2007, 50, 5471-5484.